Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: From Pathophysiology to Prevention and Treatment Based on Long-Acting Nitric Oxide Donors-Reference-Cited by-同舟云学术

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: From Pathophysiology to Prevention and Treatment Based on Long-Acting Nitric Oxide Donors

Published:2013-10-29 Issue:1 Volume:27 Page:3-13
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:American Journal of Hypertension

Author:

Kruzliak P.,Novak J.,Novak M.

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/27/1/3/5954593/hpt201.pdf

Reference92 articles.

1. Mechanisms of angiogenesis and arteriogenesis

2. Angiogenesis in cancer, vascular, rheumatoid and other disease

3. Molecular angiogenesis

4. Role of angiogenesis in tumor growth and metastasis

5. Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic hypertension with VEGFR inhibitor (axitinib) therapy in cancer patients: A meta-analysis and systematic review of randomized controlled trials;IJC Heart & Vasculature;2024-06

2. Updates in the management of cancer therapy-related hypertension;Current Opinion in Cardiology;2024-02-26

3. Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study;Cancer;2024-01-23

4. Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect;International Journal of Molecular Sciences;2023-01-24

5. Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights;Life;2022-07-12